Mechanical Insufflator-exsufflator to Control Mucus Hypersecretion in Patients in Palliative Care - A Feasibility Study
Launched by UNIVERSIDADE FEDERAL DE SAO CARLOS · Jan 7, 2016
Trial Information
Current as of June 04, 2025
Unknown status
Keywords
ClinConnect Summary
Investigators will conduct a feasibility study for a future fast track randomized trial, which will be carried out in the Américo Brasiliense State Hospital and conducted by the Spirometry and Respiratory Physiotherapy Laboratory from the Federal University of São Carlos, Brazil.
The concept of feasibility is defined as "capable of being done or carried out" and studies which aim is to verify the feasibility intends to verify if a larger clinical trial would have a acceptable probability of success in proving the efficacy of an intervention 24. The importance of feasibility studies has bee...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Prognosis:
- • Less than one year assessed by the responsible physician, with a negative answer of the to the "surprise question" - Would you be surprised if this patient died in the following year?
- • Higher than 3 months, assessed by the same physician
- * Patients with problems to deal with secretions, which could be one or both of the following problems:
- • Hypersecretion
- • Cough inefficiency (peak cough flow \<250L/min)
- • Karnofsky Performance Status Scale higher or equal to 30%;
- • Ability to give written informed consent or presence of a person who is responsable for the patient
- Exclusion Criteria:
- * Patients with conditions considered as contra-indication for the use of Mechanical Insufflator-Exsufflator:
- • Bullous emphysema history
- • Known susceptibility for pneumothorax or pneumo-mediastinum
- • Known to have had any recent barotrauma.
About Universidade Federal De Sao Carlos
The Universidade Federal de São Carlos (UFSCar) is a leading Brazilian institution dedicated to advancing research and education in the fields of science, technology, and health. With a strong emphasis on innovation and interdisciplinary collaboration, UFSCar fosters a vibrant academic environment that supports clinical trials aimed at addressing pressing health challenges. The university's commitment to high standards of ethical research and community engagement ensures that its clinical trials contribute valuable insights to the scientific community while promoting the well-being of diverse populations. Through its robust infrastructure and experienced research teams, UFSCar plays a pivotal role in advancing medical knowledge and improving patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
São Carlos, São Paulo, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials